Related Experiment Videos
Hypocarnitinemia in lysinuric protein intolerance
Stanley H Korman1, Annick Raas-Rothschild, Orly Elpeleg
1Department of Clinical Biochemistry, Hadassah University Hospital, Jerusalem, Israel. korman@hadassah.org.il
Molecular Genetics and Metabolism
|August 15, 2002
Summary
Lysinuric protein intolerance (LPI) can cause carnitine deficiency. This case study explores how carnitine intake, biosynthesis, and uptake contribute to hypocarnitinemia in an LPI patient.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Lysinuric protein intolerance (LPI) is a rare autosomal recessive metabolic disorder.
- LPI is characterized by defects in the cationic amino acid transporter, leading to hyperammonemia and other metabolic disturbances.
- Carnitine plays a crucial role in fatty acid metabolism and energy production.
Observation:
- A single previous case reported carnitine deficiency in LPI.
- We present an 11-year-old male patient diagnosed with LPI.
- The patient exhibited hypocarnitinemia, a condition of low carnitine levels.
Findings:
- This study describes hypocarnitinemia in an 11-year-old male with LPI.
- The development of hypocarnitinemia was investigated in relation to carnitine intake, biosynthesis, and cellular uptake.
- This highlights a potential metabolic consequence of LPI beyond amino acid transport defects.
Implications:
- Understanding carnitine metabolism in LPI is crucial for managing patients.
- Carnitine supplementation may be a therapeutic consideration for LPI patients with hypocarnitinemia.
- Further research is needed to elucidate the precise mechanisms linking LPI and carnitine deficiency.